[Development of a piperaquine-resistant line of Plasmodium berghei K 173 strain].
D000818:Animals; D000962:Antimalarials / Q000494:pharmacology; D037621:Artemisinins; D000077332:Artesunate; D002738:Chloroquine / Q000494:pharmacology; D004351:Drug Resistance; D008288:Malaria / Q000188:drug therapy*; D008297:Male; D015767:Mefloquine; D051379:Mice; D010962:Plasmodium berghei / Q000187:drug effects; D011804:Quinolines / Q000494:pharmacology*; D012717:Sesquiterpenes / Q000494:pharmacology; D010879:Piperazines
D000962:Antimalarials; D037621:Artemisinins; D000077332:Artesunate; D002738:Chloroquine; D015767:Mefloquine; D011804:Quinolines; D012717:Sesquiterpenes; C030684:hydroxypiperaquine; C031327:artemisinin; C034759:piperaquine; D010879:Piperazines